Evidence map›Paper›PMID 33986392›Full record

ArticleScientific reports2021

Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest.

Christoph Schriefl, Christian Schoergenhofer, Michael Poppe, Christian Clodi, Matthias Mueller, Florian Ettl, Bernd Jilma, Juergen Grafeneder, Michael Schwameis, Heidrun Losert and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biomarkers in Cardiac Arrest: A Narrative Review.Therapeutic advances in pulmonary and critical care medicine
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Christoph SchrieflDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Christian SchoergenhoferDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. christian.schoergenhofer@meduniwien.ac.at.
Michael PoppeDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Christian ClodiDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Matthias MuellerDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Florian EttlDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Bernd JilmaDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Juergen GrafenederDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Michael SchwameisDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Heidrun LosertDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Michael HolzerDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Fritz SterzDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Andrea Zeiner-SchatzlDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether admission C-reactive protein (aCRP) concentrations are associated with neurological outcome after out-of-hospital cardiac arrest (OHCA) is controversial. Based on established kinetics of CRP, we hypothesized that aCRP may reflect the pre-arrest state of health and investigated associations with neurological outcome. Prospectively collected data from the Vienna Clinical Cardiac Arrest Registry of the Department of Emergency Medicine were analysed. Adults (≥ 18 years) who suffered a non-traumatic OHCA between January 2013 and December 2018, without return of spontaneous circulation or extracorporeal cardiopulmonary resuscitation therapy were eligible. The primary endpoint was a composite of unfavourable neurologic function or death (defined as Cerebral Performance Category 3-5) at 30 days. Associations of CRP levels drawn within 30 min of hospital admission were assessed using binary logistic regression. ACRP concentrations were overall low in our population (n = 832), but higher in the unfavourable outcome group [median: 0.44 (quartiles 0.15-1.44) mg/dL vs. 0.26 (0.11-0.62) mg/dL, p < 0.001]. The crude odds ratio for higher aCRP concentrations was 1.19 (95% CI 1.10-1.28, p < 0.001, per mg/dL) to have unfavourable neurological outcome. After multivariate adjustment for traditional prognostication markers the odds ratio of higher aCRP concentrations was 1.13 (95% CI 1.04-1.22, p = 0.002). Sensitivity of aCRP was low, but specificity for unfavourable neurological outcome was 90% for the cut-off at 1.5 mg/dL and 97.5% for 5 mg/dL CRP. In conclusion, high aCRP levels are associated with unfavourable neurological outcome at day 30 after OHCA.

Indexed as

Patient AdmissionAgedBiomarkersCardiopulmonary ResuscitationCentral Nervous SystemC-Reactive ProteinFemaleHumansLimit of DetectionMaleMiddle AgedOut-of-Hospital Cardiac ArrestBiomarkersC-Reactive Protein

Identifiers

PMID33986392
PMCPMC8119412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.